Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Cmpd Licensing LLC currently has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 3 distinct examiners and 3 distinct art units. The busiest examiner, KAMM, JUDITH MARIE, is managing 2 pending actions, which represents half of the current workload.
The 4 pending office actions are handled by 3 distinct examiners, meaning that KAMM, JUDITH MARIE is the only examiner with multiple cases. This concentration of 2 busiest examiner pending actions suggests that half of the portfolio's current success depends on a single individual. The remaining 2 actions are split among 2 other distinct examiners across the 3 distinct art units.
Practitioners should focus on the specific requirements of KAMM, JUDITH MARIE while also managing the 2 other distinct examiners. The 3 distinct art units involved provide the technical framework for these Biotechnology & Pharmaceuticals matters. With 4 pending office actions, the portfolio requires a strategy that addresses both the concentrated workload of the busiest examiner and the individual styles of the other 2 examiners.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KAMM, JUDITH MARIE | 2 | 42.9% | +57.1% |
| CHICKS, ASHLI ARIANA | 1 | 60.0% | +51.0% |
| LEE, ANDREW P | 1 | 48.5% | +22.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19067198 | TOPICAL ADMINISTRATION TO THE ORAL CAVITY | KAMM, JUDITH MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19067153 | TOPICAL ADMINISTRATION TO THE ORAL CAVITY | KAMM, JUDITH MARIE | — |
| 19067198 | TOPICAL ADMINISTRATION TO THE ORAL CAVITY | KAMM, JUDITH MARIE | — |
| 18902141 | COMPOSITION AND METHOD FOR TREATING FUNGAL SKIN CONDITIONS AND INFLAMMATION | CHICKS, ASHLI ARIANA | — |
| 18119724 | TOPICAL COMPOSITIONS AND METHODS OF FORMULATING SAME | LEE, ANDREW P | — |
| Art Unit | Apps |
|---|---|
| 1611 | 2 |
| 1626 | 1 |
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19067153 | TOPICAL ADMINISTRATION TO THE ORAL CAVITY | KAMM, JUDITH MARIE | 1611 | §103Other | Final Rejection | — | Pending | Feb 28, 2025 |
| 19067198 | TOPICAL ADMINISTRATION TO THE ORAL CAVITY | KAMM, JUDITH MARIE | 1611 | §103§112Other | Final Rejection | — | Pending | Feb 28, 2025 |
| 18902141 | COMPOSITION AND METHOD FOR TREATING FUNGAL SKIN CONDITIONS AND INFLAMMATION | CHICKS, ASHLI ARIANA | 1626 | §112DP | Non-Final OA | — | Pending | Sep 30, 2024 |
| 18119724 | TOPICAL COMPOSITIONS AND METHODS OF FORMULATING SAME | LEE, ANDREW P | 1691 | §103 | Non-Final OA | — | Pending | Mar 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCmpd Licensing LLC has 4 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Judith Marie Kamm has the most, with 2 of Cmpd Licensing LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
